Liberty funds buys Lionsgate (LION) shares worth $5.2m

Published 20/06/2025, 23:18
Liberty funds buys Lionsgate (LION) shares worth $5.2m

Liberty Funds, a group of entities including Liberty 77 Fund L.P., boosted its stake in Lionsgate Studios Corp (NASDAQ:LION) with two purchases totaling $5.2 million. The purchases come as Lionsgate, currently valued at $1.65 billion, trades near its 52-week low of $5.60, having declined over 9% in the past week according to InvestingPro data.

On June 17, 2025, Liberty Funds acquired 487,400 shares of Lionsgate common stock at a weighted average price of $5.9462, in a range of $5.9000 to $6.0000, for a total value of $2,898,949. Following this, on June 20, 2025, the group purchased an additional 420,234 shares at a weighted average price of $5.6495, in a range of $5.6345 to $5.6500, for a total value of $2,373,340. The company faces significant financial challenges, with $4.76 billion in total debt and a current ratio of 0.36.

After these transactions, Liberty Funds now holds 36,896,270 shares of Lionsgate stock. The shares are held by Liberty 77 Fund L.P. and Liberty 77 Fund International L.P. Liberty 77 Capital L.P. is the investment manager of the Liberty Funds, with Liberty 77 Capital Partners (WA:CPAP) L.P. serving as its general partner. Liberty Capital L.L.C. is the general partner of Liberty 77 Capital Partners L.P., and STM Partners LLC indirectly controls the Liberty Manager. Steven T. Mnuchin is the president of STM Partners LLC. InvestingPro analysis reveals 11 additional key insights about Lionsgate’s financial health and market position.

Liberty Funds disclaims beneficial ownership of the securities except to the extent of their pecuniary interest.

In other recent news, Lionsgate Studios Corp has been the subject of various analyst assessments and strategic evaluations. Raymond (NSE:RYMD) James maintained its Outperform rating on the company, setting a price target of $10.00, despite lowering its OIBDA estimates following the underperformance of the film "Ballerina" at the box office. The film, a spinoff from the John Wick series, opened with $25 million domestically, falling short of its projected $35-40 million, and is now expected to conclude its run with $50-65 million. Despite this, Raymond James remains optimistic due to Lionsgate’s promising film slate and its potential as a merger and acquisition target.

Meanwhile, Loop Capital initiated coverage with a Hold rating and an $8.00 price target, citing the company’s current valuation and strategic position after its separation from Starz. The firm noted Lionsgate’s extensive film and TV library, generating nearly $1 billion in annual revenue, as an attractive acquisition asset. However, the company appears focused on internal growth, with a defensive strategy in place, including a poison pill provision. Analysts from both firms highlight the potential for Lionsgate to benefit from future projects, including high-profile films set for release in the coming years.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.